Killian Meara

A recent study found that, among older adults who are generally healthy and not at high risk for type 2 diabetes, Vitamin D3 supplementation does not significantly reduce the risk of developing the disease.

The higher burden of neurological symptoms among younger and middle-aged adults translated to worse subjective quality of life, according to a recent study.

A study found that patients with obesity who were diagnosed with type 2 diabetes aged 50 or younger had the highest risk of dementia.

A recent study showed that cognitive behavioral therapy could help reduce fatigue and improve concentration with moderate certainty.

Most patients with reduced opioid prescriptions during cannabis use had chronic musculoskeletal pain.

Check out this list of our top 10 stories from November 2024.

Catch up on important nonopioid pain management news from November 2024.

Catch up on important COVID-19 news from November 2024.

Catch up on important diabetes news from November 2024.

A recent study found that there was a significant relationship between self-efficacy for disease control and the level of glycemic control.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, talks about the best ways pharmacists can stay updated on advancements in diabetes medications and treatments.

Individuals who received tailored text message reminders about receiving a COVID-19 booster vaccine were more likely to get it.

Research presented at American Heart Association’s 2024 Scientific Sessions examined the SGLT inhibitor’s effect on systolic blood pressure.

“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

Three research posters presented at the American Heart Association’s 2024 Scientific Sessions looked into the use of SGLT-2 inhibitors in patients with type 2 diabetes and cardiovascular complications.

Patients with type 2 diabetes who had eating problems and higher levels of diabetes distress had worse time-in-range.

Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.

Drug Topics talked with Kelly Malkamaki, pharmacist, former independent community pharmacy owner, and senior product pharmacy analyst at AssureCare, about how community pharmacies can continue to thrive with decreased medication reimbursement rates.

Michael Ganio, PharmD, BCPS, FASHP, discusses how the industry can become more resilient.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, also discusses ways community pharmacists can collaborate with other healthcare professionals to enhance diabetes management.

A conversation with Trent Thiede, PharmD, MBA, president of PAAS National, at NCPA 2024.

A conversation with Michael Ganio, PharmD, BCPS, FASHP, senior director of Pharmacy Practice and Quality at ASHP.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how pharmacists can help with diabetes prevention and early detection in the community.

A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.

The data from PURPOSE 2 will be published in The New England Journal of Medicine.

A recent study found that with greater depression severity, metabolic and clinical characteristics such as HbA1c, fasting blood glucose, and triglyceride levels increased.

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.

Lauren Angelo, PharmD, MBA, discusses effective ways pharmacists can educate and encourage their communities on the importance of flu vaccination.